Getting Sponsor Oversight Right in Outsourced Clinical Trials
Helping sponsors design effective oversight.
Helping sponsors design effective oversight.
Sponsors increasingly rely on CROs and specialized vendors to execute clinical trials.
Monitoring activities, operational reports, and governance meetings help sponsors stay informed about study progress and key decisions.
But staying informed is not the same as having oversight.
These mechanisms are essential to trial management, yet they do not always give sponsors a clear view of how critical aspects of trial execution are being planned, performed, and overseen across sites, vendors, and processes.
Without a deliberate oversight strategy, important gaps may not become visible until they are harder to address.
Whether a sponsor is preparing for study start-up, assessing an active program, or strengthening an existing model, Silvertree helps bring greater clarity to sponsor oversight and a more deliberate approach to how it is designed and supported.
We focus on the elements that matter most across vendor selection, governance, monitoring activities, site performance, protocol deviation management, and operational risk.
The aim is to help sponsors put effective oversight in place early, understand where it may need attention, and strengthen it as programs move forward.

Support to help sponsors put the right oversight in place from the start, including governance structures, roles, escalation pathways, and core processes for outsourced clinical trials.
Structured review of an existing oversight model to identify where gaps exist, where oversight may be weak, and what needs to be strengthened.
Focused review of specific trial activities, oversight processes, or quality risk areas to provide objective insight into where attention is needed.
From planning through execution, sponsor oversight needs to be deliberate, visible, and accountable.
Silvertree BioLife
SPONSOR OVERSIGHT | CLINICAL TRIAL GOVERNANCE